Accelerated progression of coronary artery calcification in hypertension but also prehypertension

Journal of Hypertension

Volumn 34, Issue 11, 2016, Pages 2233-2242

  Lehmann, Nils ^a   Erbel, Raimund ^a   Mahabadi, Amir A ^b   Kälsch, Hagen ^b   Möhlenkamp, Stefan ^c   Moebus, Susanne ^a   Stang, Andreas ^a,d   Roggenbuck, Ulla ^a   Strucksberg, Karl Heinz ^a   Führer Sakel, Dagmar ^a   Dragano, Nico ^e   Budde, Thomas ^f   Seibel, Rainer ^g   Grönemeyer, Dietrich ^h   Jöckel, Karl Heinz ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Department of Cardiology ^*  (Germany)

^c Krankenhaus Bethanien   (Germany)

^d BOSTON UNIVERSITY   (United States)

^e UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^f ALFRIED KRUPP KRANKENHAUS   (Germany)

^g Diagnosticum Mülheim   (Germany)

^h UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Accelerated progression; Atherosclerosis; Coronary artery calcification; Hypertension; Prehypertension

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; ELECTRON BEAM TOMOGRAPHY; FEMALE; FRAMINGHAM RISK SCORE; GENDER; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREHYPERTENSION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; URBAN POPULATION; CALCINOSIS; COMPLICATION; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; MIDDLE AGED; PATHOLOGY; X-RAY COMPUTED TOMOGRAPHY;

AGED; CALCINOSIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREHYPERTENSION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84981537832     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001080     Document Type: Article

References (43)

1. Santos AB, Gupta DK, Bello NA, Gori M, Claggett B, Fuchs FD, et al. Prehypertension is associated with abnormalities of cardiac structure and function in the atherosclerosis risk in Communities Study. Am J Hypertens 2016; 29:568-574.
2. Egan BM, Stevens-Fabry S. The importance of masked hypertension in adults with prehypertension. Nat Rev Cardiol 2015; 12:497.
3. Egan BM, Stevens-Fabry S. Prehypertension-prevalence, health risks, and management strategies. Nat Rev Cardiol 2015; 12:289-300.
4. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al., Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354:1685-1697.
5. Luders S, Schrader J, Berger J, Unger T, Zidek W, Bohm M, et al., PHARAO Study Group. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens 2008; 26:1487-1496.
6. McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, et al., NAVIGATOR Study Group. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010; 362:1477-1490.
7. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Bohm M, et al., Task Force Members. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31:1281-1357.
8. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311:507-520.
9. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. Task force for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press 2014; 23:3-16.
10. Valente FM, Vespasiano P, Barbosa JA, Cesarino CB, de Andrade DO, Fernandes LA, et al. Endothelial changes in individuals with prehypertension. Curr Hypertens Rev 2016; 12:134-138.
11. Lieb W, Gona P, Larson MG, Aragam J, Zile MR, Cheng S, et al. The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern. JACC Cardiovasc Imaging 2014; 7:870-878.
12. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Circulation 1995; 92:1355-1374.
13. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20:1262-1275.
14. Budoff MJ, Mohlenkamp S, McClelland R, Delaney JA, Bauer M, Jockel HK, et al., Multi-Ethnic Study of Atherosclerosis and the Investigator Group of the Heinz Nixdorf RECALL Study. A comparison of outcomes with coronary artery calcium scanning in unselected populations: the Multi-Ethnic Study of Atherosclerosis (MESA) and Heinz Nixdorf Recall study (HNR). J Cardiovasc Comput Tomogr 2013; 7:182-191.
15. Erbel R, Mohlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, et al., Heinz Nixdorf Recall Study Investigative Group. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010; 56:1397-1406.
16. Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA, Berman D, et al. Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging 2009; 2:692-700.
17. Mohlenkamp S, Lehmann N, Moebus S, Schmermund A, Dragano N, Stang A, et al., Heinz Nixdorf Recall Study Investigators. Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality. J Am Coll Cardiol 2011; 57:1455-1464.
18. Erbel R, Lehmann N, Mohlenkamp S, Churzidse S, Bauer M, Kalsch H, et al., Heinz Nixdorf Recall Study Investigators. Subclinical coronary atherosclerosis predicts cardiovascular risk in different stages of hypertension: result of the Heinz Nixdorf Recall Study. Hypertension 2012; 59:44-53.
19. Erbel R, Lehmann N, Churzidse S, Rauwolf M, Mahabadi AA, Mohlenkamp S, et al., Heinz Nixdorf Recall Study Investigators. Progression of coronary artery calcification seems to be inevitable, but predictable-results of the Heinz Nixdorf Recall (HNR) study. Eur Heart J 2014; 35:2960-2971.
20. Schmermund A, Mohlenkamp S, Stang A, Gronemeyer D, Seibel R, Hirche H, et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL study. Risk factors, evaluation of coronary calcium and lifestyle. Am Heart J 2002; 144:212-218.
21. Stang A, Moebus S, Mohlenkamp S, Dragano N, Schmermund A, Beck EM, et al., Heinz Nixdorf Recall Study Investigative Group. Algorithms for converting random-zero to automated oscillometric blood pressure values, and vice versa. Am J Epidemiol 2006; 164:85-94.
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al., National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
23. Lehmann N, Mohlenkamp S, Mahabadi AA, Schmermund A, Roggenbuck U, Seibel R, et al. Effect of smoking and other traditional risk factors on the onset of coronary artery calcification: results of the Heinz Nixdorf Recall study. Atherosclerosis 2014; 232:339-345.
24. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-1847.
25. Detrano RC, Anderson M, Nelson J, Wong ND, Carr JJ, McNitt-Gray M, Bild DE. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility-MESA study. Radiology 2005; 236:477-484.
26. Rauwolf M, Lehmann N, Mahabadi AA, Erbel R. CAC Prediction App, 2014. freeware: https://www.uni-due.de/recall-studie/download/.
27. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005; 162:199-200.
28. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
29. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al., DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3-10.
30. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, et al., Writing Group of the PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003; 289:2083-2093.
31. Player MS, King DE, Mainous AG 3rd, Geesey ME. Psychosocial factors and progression from prehypertension to hypertension or coronary heart disease. Ann Fam Med 2007; 5:403-411.
32. Chen Y, Huang YL, Mai WY. Prehypertension or masked hypertensionwhich is responsible for target-organ damage? Nat Rev Cardiol 2015; 12:497.
33. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al., SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373:2103-2116.
34. Mahabadi AA, Lehmann N, Kalsch H, Robens T, Bauer M, Dykun I, et al. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf Recall study. JACC Cardiovasc Imaging 2014; 7:909-916.
35. Henein M, Granasen G, Wiklund U, Schmermund A, Guerci A, Erbel R, et al. High dose and long-term statin therapy accelerate coronary artery calcification. Int J Cardiol 2015; 184:581-586.
36. Dykun I, Lehmann N, Kalsch H, Bauer M, Moebus S, Mohlenkamp S, et al. Statin Intake is associated with progression of coronary artery calcium despite lowering risk for coronary events-the Heinz Nixdorf Recall study. Circulation 2014; 130:A13260.
37. Puri R, Nicholls SJ, Shao M, Kataoka Y, Uno K, Kapadia SR, et al. Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol 2015; 65:1273-1282.
38. Al-Mallah MH, Qureshi W, Lin FY, Achenbach S, Berman DS, Budoff MJ, et al. Does coronary CT angiography improve risk stratification over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results from the prospective multicenter international CONFIRM registry. Eur Heart J Cardiovasc Imaging 2014; 15:267-274.
39. Alqarqaz M, Zaidan M, Al-Mallah MH. Prevalence and predictors of atherosclerosis in symptomatic patients with zero calcium score. Acad Radiol 2011; 18:1437-1441.
40. Gottlieb I, Miller JM, Arbab-Zadeh A, Dewey M, Clouse ME, Sara L, et al. The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol 2010; 55:627-634.
41. Gassett AJ, Sheppard L, McClelland RL, Olives C, Kronmal R, Blaha MJ, et al. Risk factors for long-term coronary artery calcium progression in the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2015; 4:e001726.
42. Jockel KH, Lehmann N, Jaeger BR, Moebus S, Mohlenkamp S, Schmermund A, et al. Smoking cessation and subclinical atherosclerosis-results from the Heinz Nixdorf Recall study. Atherosclerosis 2009; 203:221-227.
43. McClelland RL, Jorgensen NW, Budoff M, Blaha MJ, Post WS, Kronmal RA, et al. 10-Year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) study and the DHS (Dallas Heart study). J Am Coll Cardiol 2015; 66:1643-1653.